FDA Panel Recommends Vertex's Telaprevir In 18-0 Vote -Bloomberg (VRTX)

by Theo Kratz, Benzinga Staff Writer
April 28, 2011 3:13 PM | 5 seconds read |
Bloomberg reports that the FDA panel recommends Vertex's VRTX Telaprevir in 18-0 vote.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: NewsFDABiotechnologyHealth Care
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved